Susquehanna International Group
AMED

Susquehanna International Group’s Amedisys AMED Stock Holding History

Susquehanna International Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,440
Closed -$609K – 12581
2025
Q1 		$597K Sell
6,440
-99,017
-94% -$9.13M ﹤0.01% 8516
2024
Q4 		$9.57M Buy
+105,457
New +$9.68M ﹤0.01% 2721
2024
Q3 		– Sell
-5,701
Closed -$556K – 11881
2024
Q2 		$523K Buy
+5,701
New +$529K ﹤0.01% 8155
2024
Q1 		– Sell
-59,679
Closed -$5.59M – 12086
2023
Q4 		$5.67M Buy
59,679
+1,965
+3% +$184K ﹤0.01% 3494
2023
Q3 		$5.39M Sell
57,714
-91,525
-61% -$8.46M ﹤0.01% 3389
2023
Q2 		$13.6M Buy
149,239
+126,583
+559% +$10.4M ﹤0.01% 2126
2023
Q1 		$1.67M Sell
22,656
-2,076
-8% -$180K ﹤0.01% 5535
2022
Q4 		$2.07M Buy
+24,732
New +$2.23M ﹤0.01% 4641
2021
Q4 		– Sell
-32,384
Closed -$5.2M – 13049
2021
Q3 		$4.83M Buy
32,384
+17,471
+117% +$3.63M ﹤0.01% 4018
2021
Q2 		$3.65M Buy
14,913
+12,576
+538% +$3.3M ﹤0.01% 4627
2021
Q1 		$619K Sell
2,337
-884
-27% -$249K ﹤0.01% 8978
2020
Q4 		$945K Sell
3,221
-22,570
-88% -$5.79M ﹤0.01% 6847
2020
Q3 		$6.1M Buy
25,791
+1,516
+6% +$345K ﹤0.01% 2807
2020
Q2 		$4.82M Buy
24,275
+15,119
+165% +$2.82M ﹤0.01% 3060
2020
Q1 		$1.68M Buy
9,156
+2,945
+47% +$524K ﹤0.01% 4291
2019
Q4 		$1.04M Sell
6,211
-8,987
-59% -$1.34M ﹤0.01% 5448
2019
Q3 		$1.99M Sell
15,198
-7,615
-33% -$991K ﹤0.01% 4205
2019
Q2 		$2.77M Sell
22,813
-15,628
-41% -$1.85M ﹤0.01% 3580
2019
Q1 		$4.74M Buy
38,441
+31,068
+421% +$3.9M ﹤0.01% 2517
2018
Q4 		$863K Sell
7,373
-6,933
-48% -$817K ﹤0.01% 4964
2018
Q3 		$1.79M Buy
+14,306
New +$1.58M ﹤0.01% 4185
2017
Q4 		– Sell
-5,150
Closed -$271K – 9175
2017
Q3 		$288K Buy
+5,150
New +$272K ﹤0.01% 7473
2017
Q2 		– Sell
-6,422
Closed -$374K – 9125
2017
Q1 		$328K Sell
6,422
-37,019
-85% -$1.77M ﹤0.01% 7192
2016
Q4 		$1.85M Buy
+43,441
New +$1.85M ﹤0.01% 4229
2016
Q3 		– Sell
-21,392
Closed -$1.07M – 8352
2016
Q2 		$1.08M Buy
21,392
+8,047
+60% +$406K ﹤0.01% 4732
2016
Q1 		$645K Buy
+13,345
New +$515K ﹤0.01% 5935
2015
Q4 		– Sell
-14,109
Closed -$564K – 9365
2015
Q3 		$536K Buy
14,109
+6,960
+97% +$294K ﹤0.01% 6988
2015
Q2 		$284K Buy
+7,149
New +$223K ﹤0.01% 8626
2015
Q1 		– Sell
-71,616
Closed -$2.02M – 9357
2014
Q4 		$2.1M Sell
71,616
-30,184
-30% -$745K ﹤0.01% 4371
2014
Q3 		$2.05M Sell
101,800
-18,670
-15% -$360K ﹤0.01% 4570
2014
Q2 		$2.02M Sell
120,470
-75,630
-39% -$1.07M ﹤0.01% 4639
2014
Q1 		$2.92M Buy
196,100
+30,200
+18% +$465K ﹤0.01% 3695
2013
Q4 		$2.43M Buy
+165,900
New +$2.67M ﹤0.01% 3959

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's AMED Position: Q2 2025 in Review

Susquehanna International Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 6,440 shares — an estimated $609K sold.

Susquehanna International Group first reported a position in AMED in Q4 2013 and held it in 33 quarters. The position peaked at $13.6M in Q2 2023. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Susquehanna International Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 6,440 Amedisys shares in Q2 2025, an estimated $609K.
  • Susquehanna International Group first reported a position in Amedisys in Q4 2013 and held it in 33 quarters.
  • Susquehanna International Group's Amedisys position peaked at $13.6M in Q2 2023.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.